Clinical Trials Browser

Adenomatous Polyposis Coli × 30 days × Clear all

NCT05630794 2026-03-19

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Phase 1 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06557733 2026-03-19

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Phase 2 Not yet recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT05223036 2026-03-18

Testing Obeticholic Acid for Familial Adenomatous Polyposis

Phase 2 Suspended

Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06950385 2026-03-17

SERENTA

Phase 3 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Polyps

NCT07463599 2026-03-11

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT07461246 2026-03-10

RIPAF

Active not recruiting

GastrointestinalSarcoma

Turcot syndrome, Attenuated familial adenomatous polyposis, Polyposis Syndrome, Hereditary Mixed, 1, Gardner Syndrome, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Colorectal Neoplasms, Desmoid Tumors

NCT04677998 2026-02-23

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

Gastrointestinal

Adenomatous Polyposis Coli